Cargando…

Guided Antitumoural Drugs: (Imidazol‐2‐ylidene)(L)gold(I) Complexes Seeking Cellular Targets Controlled by the Nature of Ligand L

Three [1,3‐diethyl‐4‐(p‐methoxyphenyl)‐5‐(3,4,5‐trimethoxyphenyl)imidazol‐2‐ylidene](L)gold(I) complexes, 4 a (L=Cl), 5 a (L=PPh(3)), and 6 a (L=same N‐heterocyclic carbene (NHC)), and their fluorescent [4‐(anthracen‐9‐yl)‐1,3‐diethyl‐5‐phenylimidazol‐2‐ylidene](L)gold(I) analogues, 4 b, 5 b, and 6 ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bär, Sofia I., Gold, Madeleine, Schleser, Sebastian W., Rehm, Tobias, Bär, Alexander, Köhler, Leonhard, Carnell, Lucas R., Biersack, Bernhard, Schobert, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Full Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7986617/ https://www.ncbi.nlm.nih.gov/pubmed/33369765 http://dx.doi.org/10.1002/chem.202005451

Ejemplares similares

Revisiting the anticancer properties of phosphane(9-ribosylpurine-6-thiolato)gold(I) complexes and their 9H-purine precursors
por: Kober, Luisa, et al.
Publicado: (2022)

New 4,5-Diarylimidazol-2-ylidene–iodidogold(I) Complexes with High Activity against Esophageal Adenocarcinoma Cells
por: Schleser, Sebastian W., et al.
Publicado: (2023)

3D cell cultures, as a surrogate for animal models, enhance the diagnostic value of preclinical in vitro investigations by adding information on the tumour microenvironment: a comparative study of new dual-mode HDAC inhibitors
por: Bär, Sofia I., et al.
Publicado: (2022)

Imidazole Analogs of Vascular-Disrupting Combretastatin A-4 with Pleiotropic Efficacy against Resistant Colorectal Cancer Models
por: Reipsch, Franziska, et al.
Publicado: (2021)

2‐Amino‐4‐aryl‐5‐oxo‐4,5‐dihydropyrano[3,2‐c]chromene‐3‐carbonitriles with Microtubule‐Disruptive, Centrosome‐Declustering, and Antiangiogenic Effects in vitro and in vivo
por: Köhler, Leonhard H. F., et al.
Publicado: (2022)

Multimodal 4-arylchromene derivatives with microtubule-destabilizing, anti-angiogenic, and MYB-inhibitory activities
por: Köhler, Leonhard H. F., et al.
Publicado: (2023)

Novel Anticancer NHC*-Gold(I) Complexes Inspired by Lepidiline A
por: Curran, Danielle, et al.
Publicado: (2020)

Half-sandwich nickel(II) complexes bearing 1,3-di(cycloalkyl)imidazol-2-ylidene ligands
por: Yau, Johnathon, et al.
Publicado: (2015)

Crystal structures of the gold NHC complex bis(4-bromo-1,3-diethylimidazol-2-ylidene)gold(I) iodide and its 1:1 adduct with trans-bis(4-bromo-1,3-diethyl-imidazol-2-ylidene)diiodidogold(III) iodide
por: Büssing, Rolf, et al.
Publicado: (2021)

A New Pentafluorothio-Substituted Curcuminoid with Superior Antitumor Activity
por: Linder, Benedikt, et al.
Publicado: (2021)

Antitumor Effects of a New Retinoate of the Fungal Cytotoxin Illudin M in Brain Tumor Models
por: Linder, Benedikt, et al.
Publicado: (2022)

Chimeric HDAC and the cytoskeleton inhibitor broxbam as a novel therapeutic strategy for liver cancer
por: Bär, Sofia Isolde, et al.
Publicado: (2022)

Monitoring of circulating epithelial tumor cells using the Maintrac(®) method and its potential benefit for the treatment of patients with colorectal cancer
por: Gold, Madeleine, et al.
Publicado: (2021)

Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity
por: Yusenko, Maria V., et al.
Publicado: (2021)

Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes
por: Lettl, Clara, et al.
Publicado: (2020)

Fluorinated and N-Acryloyl-Modified 3,5-Di[(E)-benzylidene]piperidin-4-one Curcuminoids for the Treatment of Pancreatic Carcinoma
por: Ghosh, Hindole, et al.
Publicado: (2023)

Ligands stimulating antitumour immunity as the next G-quadruplex challenge
por: Miglietta, Giulia, et al.
Publicado: (2022)

trans-Dibromidobis(1-ethyl-3-methylimidazol-2-ylidene)palladium(II)
por: Madsen, Solveig R., et al.
Publicado: (2011)

The enhanced antitumour response of pimozide combined with the IDO inhibitor L-MT in melanoma
por: Jia, Huijie, et al.
Publicado: (2018)

Tricarbonylbis(1,3-diisopropyl-4,5-dimethylimidazol-2-ylidene)iron
por: Ahmida, Aziza, et al.
Publicado: (2012)

Imidazol-2-ylidene stabilized tetrahedral cobalt carbonyl complexes: A computational and structural database study
por: Tetteh, Samuel
Publicado: (2019)

The In Vitro Antitumour Activity of Novel, Mitochondrial-Interactive, Gold-Based Lipophilic Cations
por: Mahepal, Sherika, et al.
Publicado: (2008)

Antiparasitic Activity of Fluorophenyl-Substituted Pyrimido[1,2-a]benzimidazoles
por: Nasr, Ibrahim S. Al, et al.
Publicado: (2023)

Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells
por: Schleser, Sebastian W., et al.
Publicado: (2023)

Internal and External Influences on Stability and Ligand Exchange Reactions in Bromido[3-ethyl-4-aryl-5-(2-methoxypyridin-5-yl)-1-propyl-1,3-dihydro-2H-imidazol-2-ylidene]gold(I) Complexes
por: Goetzfried, Sina Katharina, et al.
Publicado: (2021)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

Complexes of gold and imidazole formed in helium nanodroplets
por: Gatchell, Michael, et al.
Publicado: (2018)

Synthesis and Anticancer Evaluation of New Indole-Based Tyrphostin Derivatives and Their (p-Cymene)dichloridoruthenium(II) Complexes
por: Oberhuber, Natalie, et al.
Publicado: (2023)

Synthesis and Bioactivity of Ancorinoside B, a Marine Diglycosyl Tetramic Acid
por: Soliga, Kevin J., et al.
Publicado: (2021)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Interaction of Imidazole Containing Hydroxamic Acids with Fe(III): Hydroxamate Versus Imidazole Coordination of the Ligands
por: Farkas, Etelka, et al.
Publicado: (2007)

Anticancer Activity and Mechanisms of Action of New Chimeric EGFR/HDAC-Inhibitors
por: Goehringer, Nils, et al.
Publicado: (2021)

A New Synthetic Curcuminoid Displays Antitumor Activities in Metastasized Melanoma
por: Kaps, Leonard, et al.
Publicado: (2023)

Quantiferon-TB Gold test in screening for latent tuberculosis before and during antitumour necrosis factor treatment
por: Vencovský, J, et al.
Publicado: (2007)

Bis[1-benzyl-3-(4-methylphenyl)imidazol-2-ylidene]silver(I) hexafluoridophosphate
por: Huang, Kun, et al.
Publicado: (2011)

Cobalt 1,3-Diisopropyl-1H-imidazol-2-ylidene Complexes: Synthesis, Solid-State Structures, and Quantum Chemistry Calculations
por: Vélez, Carmen L., et al.
Publicado: (2010)

Novel 2-Acetamido-2-ylidene-4-imidazole Derivatives (El-Saghier Reaction): Green Synthesis, Biological Assessment, and Molecular Docking
por: El-Saghier, Ahmed M., et al.
Publicado: (2023)

Tin-based Antitumour Drugs
por: Gielen, Marcel
Publicado: (1994)

The realisation of targeted antitumour therapy
por: Bicknell, R
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_bn93kg8f7erupj5nm8mk8enpa8